AG2R Citroën deny interest in signing Nairo Quintana
Options are running out for the Colombian, as is time
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Sign up to our newsletter Newsletter

Cycling teams do not normally take the step of responding to transfer speculation; it usually all happens behind closed doors, with agents trying to arrange things away from prying eyes. You will see a rumour in the media, but rarely an official confirmation or denial, until business is finally done.
This is what makes AG2R Citroën's official denial of interest in signing Nairo Quintana all the more interesting. Not only were they willing to tell people off the record that it wasn't happening, they felt they had to issue a firm rebuttal to the speculation.
"Contrary to an information released in different medias AG2R CITROËN TEAM has never had any contact with Nairo Quintana or his agent and is not interested by his recruitment," a message from the team read on Tuesday morning.
What this says about Quintana's status within the sport after his retrospective disqualification from the 2022 Tour de France, after two of his blood samples revealed the presence of the painkiller tramadol, or AG2R's need to reassure their riders or investors, is an interesting question.
While the World Anti-Doping Association (WADA) didn’t include tramadol on its banned substance list, the painkiller had been banned by the UCI since March 2019 due to its adverse side effects. WADA has since outlawed its use.
The Colombian announced he will leave Arkéa-Samsic at the end of this season, just six weeks after he agreed a new three-year deal with the French team.
“I want to thank Arkéa-Samsic for these last three years,” the Colombian said in a message shared on his Instagram account. “We’ve had ups and downs, but I’ve been able to bring my experience to the team and collect UCI points.”
While the contract extension was announced by the team, French media said that nothing was officially signed between the rider and the team, which allowed Arkéa and Quintana to part ways.
French newspaper L'Equipe (opens in new tab) reported over the weekend that a separate French team had made a contract proposal, with their piece saying that it was a WorldTour squad.
The report cited "sources close to the Colombian", noting that a French team had already made him a contract proposal. With AG2R out, this leaves Cofidis or Groupama-FDJ, neither of whom have said anything, but the French paper also reported that Astana-Qazaqstan were interested; this might make more sense, with Vincenzo Nibali retiring this year.
However, time and opportunities are running out for the Colombian, who still has his disqualification due to tramadol and appeal to the Court of Arbitration for Sport hanging over him.
In his Instagram message over the weekend, Quintana said: “I will keep you informed on my future in the coming weeks and prove what an honest rider I am.
“I have brought an appeal before the CAS and I’m continuing to work with my team of lawyers. I’m optimistic because I am an honest person, I’ve done nothing wrong or illegal and I want to defend myself.”
With Quintana departing Arkéa, along with Brit Connor Swift, who has moved to Ineos Grenadiers, there are now spaces and funds available at the French ProTour team.
Thank you for reading 10 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Adam is Cycling Weekly’s senior news and feature writer – his greatest love is road racing but as long as he is cycling on tarmac, he's happy. Before joining Cycling Weekly he spent two years writing for Procycling, where he interviewed riders and wrote about racing, speaking to people as varied as Demi Vollering to Philippe Gilbert. Before cycling took over his professional life, he covered ecclesiastical matters at the world’s largest Anglican newspaper and politics at Business Insider. Don't ask how that is related to cycling.
-
-
Saved by a doping test: The pro rider treated for cancer after abnormal blood result
When his team doctor called about an abnormal test result, Torstein Træen could not believe what was happening – but it would turn out to be a potentially life-saving red flag
By Chris Marshall-Bell • Published
-
'No regrets' for Tadej Pogačar after falling short of Milan-San Remo podium
UAE Team Emirates rider says the best man won on the Via Roma
By Tom Davidson • Published
-
Nairo Quintana says he's not retiring. What next?
The Colombian, let go by Arkéa-Samsic last year, is still without a team, but wants to race on
By Adam Becket • Published
-
Nairo Quintana says 'keep calm', he’s got a team for next season
The Colombian has been rumoured with a number of WorldTour teams
By Tom Davidson • Published
-
Nairo Quintana withdraws from Vuelta a España: 'I will assert my reasons before the Court of Arbitration for Sport'
The UCI announced the Colombian had tested positive for tramadol twice at the Tour de France, and has been retroactively disqualified
By Ryan Dabbs • Published
-
Nairo Quintana disqualified from Tour de France after twice testing positive for tramadol
The Colombian will still race at the Vuelta a España because it is not considered a doping violation
By Ryan Dabbs • Published
-
AG2R Citroën manager ambitious going into new season: 'We want to win a Monument'
Vincent Lavenu also expects a more competitive challenge in the general classification of a Grand Tour
By Ryan Dabbs • Published
-
Tadej Pogačar is 'pretty much untouchable' says Ben O'Connor
Fourth place finish at Tour de France still seems ridiculous, says Australian rider
By Adam Becket • Published
-
Arkéa-Samsic manager says they are 'at the gates of the WorldTour' with aims to join in 2023
The team of Nairo Quintana will get an automatic invite to every WorldTour race in 2022
By Tim Bonville-Ginn • Published
-
UCI ‘firmly condemns racist attacks’ against Nacer Bouhanni
The UCI says it “firmly condemns the racist attacks” aimed at Nacer Bouhanni.
By Alex Ballinger • Published